Arbutus Biopharma Corporation
NasdaqGS:ABUS
$ 2.89
+ $0.08 (2.85%)
$ 2.89
+ $0.08 (2.85%)
End-of-day quote: 05/16/2024

Arbutus Biopharma financials at a glance

The revenue of Arbutus Biopharma is reported as 0.02463 billion Dollars in the fiscal year 2023. The earnings were -0.6 Dollars per share in 2023, which was 4.76 higher than 2022. And about -0.00101 billion Dollars are reported as free cash flow in the financials of Arbutus Biopharma 2023. No dividends were paid to the shareholders of the Arbutus Biopharma stock NasdaqGS:ABUS in the financial year 2023.

$24.63M
Revenue
$-0.60
Earnings Per Share
100.00%
Gross Margin %
$0.00M
Free Cash Flow
Revenue
24.63
Earnings Per Share
-0.60
Gross Margin %
100.00
Free Cash Flow
0.00

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Rev. Revenue N/A $24.63M $53.12M $13.92M $8.72M $8.06M $7.93M $13.84M $2.00M $32.99M $19.04M $17.00M $14.11M $16.65M $21.35M
GM % Gross Margin % -,255.58% 100.00% -,116.33% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -,103.24% -,158.90% -38.75% -27.92% -19.75% -3.65%
OM Operating Margin 0.00% 0.00% -,162.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -,219.35% -,220.50% -78.58% -91.78% -63.61% -30.90%
EPS Earnings Per Share $-0.46 $-0.60 $-0.63 $-1.05 $-1.26 $-2.30 $-1.97 $-1.41 $-1.65 $-0.64 $-2.30 $-1.01 $2.08 $-0.88 $-0.63
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares N/AM 179.49M 162.57M 148.64M 95.58M 68.94M 56.12M 55.06M 54.84M 54.63M 46.57M 19.69M 14.31M 14M 10.34M
OCF Operating Cash Flow N/A $0.00M $0.00M $-85.16M $-64.80M $-95.18M $-91.18M $-63.69M $-77.32M $-72.59M $-15.88M $-7.39M $0.00M $0.00M $-11.25M
FCF Free Cash Flow N/A $0.00M $0.00M $-85.97M $-65.09M $-95.97M $-92.32M $-73.20M $-81.32M $-74.88M $-17.23M $-8.19M $0.00M $0.00M $-12.08M
FCFS Free Cash Flow Per Share $-0.53 $-0.52 $-0.24 $-0.64 $-0.68 $-1.25 $-1.25 $-1.02 $-1.17 $-1.29 $-0.62 $-0.49 $2.40 $-0.70 $-1.17